Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes Discussion
Ask A Question
DO YOU WANT TO JOIN ME TO MAKE A CHANGE TO CURRENT GUIDELINES?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Debandez" data-source="post: 2162876" data-attributes="member: 460354"><p>I'm researching this now. It may take time to get letter together as so busy for a week or so. </p><p></p><p>Got this reply from my surgery today. Sharing for info (and to give you a laugh). The first sentence made me choke on my cornflakes! Yes of course I'm joking......I wasnt choking ;-)</p><p></p><p>We have recently had correspondence regarding BM machines.</p><p></p><p>The following is the information the CCG meds management team have sent</p><p></p><p></p><p>“Self-monitoring of blood glucose (SMBG) is of limited clinical effectiveness in improving blood glucose control in patients with Type 2 Diabetes Mellitus (T2DM) on oral therapies or diet control and therefore is unlikely to be cost effective.</p><p></p><p>SMBG in T2DM is usually advised where a patient:</p><p>· is on insulin or</p><p>· there is evidence of hypoglycaemia or</p><p>· the person is on oral medication that may increase their risk of hypoglycaemia (while driving/operating machinery)</p><p>· or the person is pregnant, or is planning to become pregnant,</p><p>and the patient has an understanding of the benefits of monitoring and how to interpret the results i.e. reinforce lifestyle changes or adjust therapy accordingly.</p><p></p><p>Patients who gain no clinical benefit from SMBG should be discouraged from testing.</p><p></p><p>Prescribing of BGTS should be reviewed to ensure that testing is appropriate. IF test strips are indicated, quantities & frequency of issue should be reviewed to avoid wastage. Please see LMMG guidance for frequency of monitoring & appropriate quantities to supply</p><p></p><p><a href="https://www.lancsmmg.nhs.uk/download/guidelines/LMMG-Blood-Glucose-Testing-Guidance-V1.1-FOR-WEBSITE2.pdf" target="_blank">https://www.lancsmmg.nhs.uk/download/guidelines/LMMG-Blood-Glucose-Testing-Guidance-V1.1-FOR-WEBSITE2.pdf</a></p><p></p><p>Please also find attached up to date data for the prescribing of test strips in patients with T2DM who do not appear to be prescribed insulin, a sulphonylurea or a glinide.</p><p></p><p>Kind regards</p><p></p><p>Medicines Optimisation Team”</p><p></p><p>Hope this is useful information.</p><p></p><p>Best wishes,</p></blockquote><p></p>
[QUOTE="Debandez, post: 2162876, member: 460354"] I'm researching this now. It may take time to get letter together as so busy for a week or so. Got this reply from my surgery today. Sharing for info (and to give you a laugh). The first sentence made me choke on my cornflakes! Yes of course I'm joking......I wasnt choking ;-) We have recently had correspondence regarding BM machines. The following is the information the CCG meds management team have sent “Self-monitoring of blood glucose (SMBG) is of limited clinical effectiveness in improving blood glucose control in patients with Type 2 Diabetes Mellitus (T2DM) on oral therapies or diet control and therefore is unlikely to be cost effective. SMBG in T2DM is usually advised where a patient: · is on insulin or · there is evidence of hypoglycaemia or · the person is on oral medication that may increase their risk of hypoglycaemia (while driving/operating machinery) · or the person is pregnant, or is planning to become pregnant, and the patient has an understanding of the benefits of monitoring and how to interpret the results i.e. reinforce lifestyle changes or adjust therapy accordingly. Patients who gain no clinical benefit from SMBG should be discouraged from testing. Prescribing of BGTS should be reviewed to ensure that testing is appropriate. IF test strips are indicated, quantities & frequency of issue should be reviewed to avoid wastage. Please see LMMG guidance for frequency of monitoring & appropriate quantities to supply [URL]https://www.lancsmmg.nhs.uk/download/guidelines/LMMG-Blood-Glucose-Testing-Guidance-V1.1-FOR-WEBSITE2.pdf[/URL] Please also find attached up to date data for the prescribing of test strips in patients with T2DM who do not appear to be prescribed insulin, a sulphonylurea or a glinide. Kind regards Medicines Optimisation Team” Hope this is useful information. Best wishes, [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Discussion
Ask A Question
DO YOU WANT TO JOIN ME TO MAKE A CHANGE TO CURRENT GUIDELINES?
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…